OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats
Roohi Mirza, Bhupesh Sharma
Life Sciences (2018) Vol. 214, pp. 106-117
Closed Access | Times Cited: 44
Roohi Mirza, Bhupesh Sharma
Life Sciences (2018) Vol. 214, pp. 106-117
Closed Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats
Roohi Mirza, Bhupesh Sharma
Brain Research Bulletin (2019) Vol. 147, pp. 36-46
Closed Access | Times Cited: 64
Roohi Mirza, Bhupesh Sharma
Brain Research Bulletin (2019) Vol. 147, pp. 36-46
Closed Access | Times Cited: 64
Fecal Transplant and Bifidobacterium Treatments Modulate Gut Clostridium Bacteria and Rescue Social Impairment and Hippocampal BDNF Expression in a Rodent Model of Autism
Sameera Abuaish, Norah M. Al-Otaibi, Turki S. Abujamel, et al.
Brain Sciences (2021) Vol. 11, Iss. 8, pp. 1038-1038
Open Access | Times Cited: 49
Sameera Abuaish, Norah M. Al-Otaibi, Turki S. Abujamel, et al.
Brain Sciences (2021) Vol. 11, Iss. 8, pp. 1038-1038
Open Access | Times Cited: 49
Lactobacillus plantarum PS128 prevents cognitive dysfunction in Alzheimer’s disease mice by modulating propionic acid levels, glycogen synthase kinase 3 beta activity, and gliosis
Hei-Jen Huang, Jie-Ling Chen, Jian-Fu Liao, et al.
BMC Complementary Medicine and Therapies (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 43
Hei-Jen Huang, Jie-Ling Chen, Jian-Fu Liao, et al.
BMC Complementary Medicine and Therapies (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 43
Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism
Rishabh Khera, Sidharth Mehan, Sonalika Bhalla, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 889-889
Open Access | Times Cited: 37
Rishabh Khera, Sidharth Mehan, Sonalika Bhalla, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 889-889
Open Access | Times Cited: 37
A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress
Roohi Mirza, Bhupesh Sharma
Chemico-Biological Interactions (2019) Vol. 311, pp. 108758-108758
Closed Access | Times Cited: 53
Roohi Mirza, Bhupesh Sharma
Chemico-Biological Interactions (2019) Vol. 311, pp. 108758-108758
Closed Access | Times Cited: 53
Beneficial effects of pioglitazone, a selective peroxisome proliferator‐activated receptor‐γ agonist in prenatal valproic acid‐induced behavioral and biochemical autistic like features in Wistar rats
Roohi Mirza, Bhupesh Sharma
International Journal of Developmental Neuroscience (2019) Vol. 76, Iss. 1, pp. 6-16
Closed Access | Times Cited: 49
Roohi Mirza, Bhupesh Sharma
International Journal of Developmental Neuroscience (2019) Vol. 76, Iss. 1, pp. 6-16
Closed Access | Times Cited: 49
Propionic acid induced behavioural effects of relevance to autism spectrum disorder evaluated in the hole board test with rats
Melissa M. Meeking, Derrick F. MacFabe, Jennifer Mepham, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 97, pp. 109794-109794
Closed Access | Times Cited: 45
Melissa M. Meeking, Derrick F. MacFabe, Jennifer Mepham, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 97, pp. 109794-109794
Closed Access | Times Cited: 45
Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats via inhibiting apoptosis-related glycolysis
Ayman E. El-Sahar, Alyasaa A. Rastanawi, Muhammed F. El-Yamany, et al.
Life Sciences (2020) Vol. 257, pp. 118076-118076
Closed Access | Times Cited: 44
Ayman E. El-Sahar, Alyasaa A. Rastanawi, Muhammed F. El-Yamany, et al.
Life Sciences (2020) Vol. 257, pp. 118076-118076
Closed Access | Times Cited: 44
Impact of GABA and nutritional supplements on neurochemical biomarkers in autism: a PPA rodent model study
Altaf Alabdali, Abir Ben Bacha, Mona Alonazi, et al.
Frontiers in Molecular Neuroscience (2025) Vol. 18
Open Access
Altaf Alabdali, Abir Ben Bacha, Mona Alonazi, et al.
Frontiers in Molecular Neuroscience (2025) Vol. 18
Open Access
Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173663-173663
Closed Access | Times Cited: 36
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173663-173663
Closed Access | Times Cited: 36
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Autism Research (2021) Vol. 14, Iss. 11, pp. 2270-2286
Closed Access | Times Cited: 31
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Autism Research (2021) Vol. 14, Iss. 11, pp. 2270-2286
Closed Access | Times Cited: 31
Cardiovascular therapeutics: A new potential for anxiety treatment?
Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1202-1245
Open Access | Times Cited: 20
Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1202-1245
Open Access | Times Cited: 20
Bee pollen and propolis improve neuroinflammation and dysbiosis induced by propionic acid, a short chain fatty acid in a rodent model of autism
Kawther Aabed, Ramesa Shafi Bhat, Abeer Al‐Dbass, et al.
Lipids in Health and Disease (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 34
Kawther Aabed, Ramesa Shafi Bhat, Abeer Al‐Dbass, et al.
Lipids in Health and Disease (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 34
The Role of Lipidomics in Autism Spectrum Disorder
Afaf El‐Ansary, Salvatore Chirumbolo, Ramesa Shafi Bhat, et al.
Molecular Diagnosis & Therapy (2019) Vol. 24, Iss. 1, pp. 31-48
Closed Access | Times Cited: 31
Afaf El‐Ansary, Salvatore Chirumbolo, Ramesa Shafi Bhat, et al.
Molecular Diagnosis & Therapy (2019) Vol. 24, Iss. 1, pp. 31-48
Closed Access | Times Cited: 31
Behavioural and brain ultrastructural changes following the systemic administration of propionic acid in adolescent male rats. Further development of a rodent model of autism
Giorgi Lobzhanidze, Nadezhda Japaridze, Tamar Lordkipanidze, et al.
International Journal of Developmental Neuroscience (2020) Vol. 80, Iss. 2, pp. 139-156
Closed Access | Times Cited: 30
Giorgi Lobzhanidze, Nadezhda Japaridze, Tamar Lordkipanidze, et al.
International Journal of Developmental Neuroscience (2020) Vol. 80, Iss. 2, pp. 139-156
Closed Access | Times Cited: 30
Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase
Haley A. Vecchiarelli, Maria Morena, Catherine M. Keenan, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 5, pp. 992-1003
Open Access | Times Cited: 23
Haley A. Vecchiarelli, Maria Morena, Catherine M. Keenan, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 5, pp. 992-1003
Open Access | Times Cited: 23
Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats
Arushi Sandhu, Kajal Rawat, Vipasha Gautam, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 237, pp. 173721-173721
Closed Access | Times Cited: 2
Arushi Sandhu, Kajal Rawat, Vipasha Gautam, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 237, pp. 173721-173721
Closed Access | Times Cited: 2
A snapshot on introspection of autism spectrum disorder
Govind Kale, Veeranjaneyulu Addepalli, Sharvari Joshi
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Govind Kale, Veeranjaneyulu Addepalli, Sharvari Joshi
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination
Esraa M. Elnahas, Sally A. Abuelezz, Magda I. Mohamad, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 116, pp. 110522-110522
Closed Access | Times Cited: 11
Esraa M. Elnahas, Sally A. Abuelezz, Magda I. Mohamad, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 116, pp. 110522-110522
Closed Access | Times Cited: 11
PPARα Signaling: A Candidate Target in Psychiatric Disorder Management
Simona Scheggi, Graziano Pinna, Giulia Braccagni, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 723-723
Open Access | Times Cited: 11
Simona Scheggi, Graziano Pinna, Giulia Braccagni, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 723-723
Open Access | Times Cited: 11
Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Journal of Pharmacy and Pharmacology (2021) Vol. 73, Iss. 11, pp. 1460-1469
Closed Access | Times Cited: 14
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Journal of Pharmacy and Pharmacology (2021) Vol. 73, Iss. 11, pp. 1460-1469
Closed Access | Times Cited: 14
Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder
Arushi Sandhu, Kajal Rawat, Vipasha Gautam, et al.
Brain Research (2023) Vol. 1815, pp. 148443-148443
Closed Access | Times Cited: 5
Arushi Sandhu, Kajal Rawat, Vipasha Gautam, et al.
Brain Research (2023) Vol. 1815, pp. 148443-148443
Closed Access | Times Cited: 5
Papaverine ameliorates prenatal alcohol‐induced experimental attention deficit hyperactivity disorder by regulating neuronal function, inflammation, and oxidative stress
Niti Sharma, Neerupma Dhiman, Lalit K. Golani, et al.
International Journal of Developmental Neuroscience (2020) Vol. 81, Iss. 1, pp. 71-81
Closed Access | Times Cited: 13
Niti Sharma, Neerupma Dhiman, Lalit K. Golani, et al.
International Journal of Developmental Neuroscience (2020) Vol. 81, Iss. 1, pp. 71-81
Closed Access | Times Cited: 13
Evaluation of Wnt/β-catenin signaling and its modulators in repeated dose lithium-pilocarpine rat model of status epilepticus: An acute phase study
Vipasha Gautam, Kajal Rawat, Arushi Sandhu, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176375-176375
Closed Access | Times Cited: 1
Vipasha Gautam, Kajal Rawat, Arushi Sandhu, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176375-176375
Closed Access | Times Cited: 1
Effect of papaverine on developmental hyperserotonemia induced autism spectrum disorder related behavioural phenotypes by altering markers of neuronal function, inflammation, and oxidative stress in rats
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Clinical and Experimental Pharmacology and Physiology (2021) Vol. 48, Iss. 4, pp. 614-625
Closed Access | Times Cited: 8
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Clinical and Experimental Pharmacology and Physiology (2021) Vol. 48, Iss. 4, pp. 614-625
Closed Access | Times Cited: 8
